Stock analysts at Credit Suisse Group started coverage on shares of Core Laboratories (NYSE:CLB) in a report issued on Thursday. The firm set an “outperform” rating and a $107.94 price target on the oil and gas company’s stock. Credit Suisse Group’s price target indicates a potential upside of 1.13% from the stock’s current price.
Several other analysts also recently issued reports on CLB. TheStreet raised shares of Core Laboratories from a “c” rating to a “b-” rating in a research note on Thursday, February 1st. Piper Jaffray Companies began coverage on shares of Core Laboratories in a research note on Tuesday. They set a “neutral” rating and a $96.00 target price on the stock. ValuEngine downgraded shares of Core Laboratories from a “hold” rating to a “sell” rating in a research note on Thursday, March 1st. Zacks Investment Research raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research note on Tuesday, March 6th. Finally, Deutsche Bank downgraded shares of Core Laboratories from a “buy” rating to a “hold” rating and cut their target price for the company from $116.30 to $109.00 in a research note on Thursday, January 11th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $111.39.
Core Laboratories (NYSE:CLB) opened at $106.73 on Thursday. The stock has a market capitalization of $4,654.03, a price-to-earnings ratio of 56.77 and a beta of 1.47. Core Laboratories has a twelve month low of $86.55 and a twelve month high of $121.39. The company has a debt-to-equity ratio of 1.53, a current ratio of 1.98 and a quick ratio of 1.66.
Core Laboratories (NYSE:CLB) last announced its earnings results on Wednesday, January 31st. The oil and gas company reported $0.58 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.58. Core Laboratories had a net margin of 12.60% and a return on equity of 58.25%. The company had revenue of $172.00 million for the quarter, compared to the consensus estimate of $171.92 million. During the same period in the previous year, the business earned $0.41 EPS. The company’s revenue was up 15.1% on a year-over-year basis. equities research analysts forecast that Core Laboratories will post 2.7 EPS for the current fiscal year.
Several institutional investors have recently bought and sold shares of CLB. The Manufacturers Life Insurance Company grew its holdings in shares of Core Laboratories by 63.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,128 shares of the oil and gas company’s stock valued at $114,000 after acquiring an additional 439 shares in the last quarter. Robeco Institutional Asset Management B.V. grew its holdings in shares of Core Laboratories by 60.7% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 1,096 shares of the oil and gas company’s stock valued at $120,000 after acquiring an additional 414 shares in the last quarter. Captrust Financial Advisors purchased a new position in shares of Core Laboratories during the 4th quarter valued at $139,000. Toronto Dominion Bank grew its holdings in shares of Core Laboratories by 243.6% during the 3rd quarter. Toronto Dominion Bank now owns 1,866 shares of the oil and gas company’s stock valued at $184,000 after acquiring an additional 1,323 shares in the last quarter. Finally, Teachers Advisors LLC grew its holdings in shares of Core Laboratories by 56.6% during the 4th quarter. Teachers Advisors LLC now owns 1,779 shares of the oil and gas company’s stock valued at $195,000 after acquiring an additional 643 shares in the last quarter.
ILLEGAL ACTIVITY WARNING: “Credit Suisse Group Initiates Coverage on Core Laboratories (CLB)” was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://ledgergazette.com/2018/03/17/credit-suisse-group-initiates-coverage-on-core-laboratories-clb.html.
About Core Laboratories
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.